Donald Cutlip

Showing 1-13 of 13 articles

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Sorting out coronary stents, as time goes by

Stefanini G, Cutlip D

December 20, 2017 | 10.4244/EIJV13I11A198

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

Kappetein AP, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M

November 20, 2012 | 10.4244/EIJV8I7A121

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population

Vranckx P, McFadden E, Mehran R, Cutlip D

July 27, 2012 | 10.4244/EIJV8I3A56

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P

February 25, 2010

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

Meredith I, Worthley S, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins G, Hendriks R, Matsis P, Muller D, Cutlip D

January 15, 2010

Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions

Piazza N, Cutlip D, Onuma Y, Kappetein AP, de Jaegere P, Serruys P

May 19, 2009

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

Vranckx P, Kint P-P, Morel M, Van Es G-A, Serruys P, Cutlip D

August 20, 2008

An introduction to "A critical appraisal of the safety concerns tempering the success of drug-eluting stents"

Daemen J, Cutlip D, Windecker S

August 20, 2008

The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial

Meredith I, Worthley S, Whitbourn R, Walters D, Popma J, Cutlip D, Fitzgerald P

May 22, 2007

Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial

Holmes D, Coolong A, O’ Shaughnessy C, Chauhan M, van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma J, Cutlip D, Kuntz R

August 20, 2006

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial

Meredith I, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma J, Cutlip D, Fitzgerald P, Prpic R, Kuntz R

August 20, 2005

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Ahead of print: Leaflex Study

September 23, 2020

Integrating physiology in OCT

September 23, 2020

BioFlow IV, TWILIGHT, Evolut Low Risk and many others

(Released thanks to the support of Biotronik)

September 25, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Steady-state hyperaemia

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease